The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · cited 1×
“Moreover, Her-2/neu overexpression occurs in 20% of breast carcinomas and is associated with unfavorable clinical outcome and resistance to chemotherapy [53–56].”
BackgroundStudies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Berenbaum, M. C. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00026-2 · Cited by 1,414
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
The neu oncogene encodes an epidermal growth factor receptor-related protein
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Nature · doi:10.1038/319226a0 · Cited by 1,117
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987) · Science · doi:10.1126/science.2885917 · Cited by 1,010
Ross, J. S., & Fletcher, J. A. (1998) · STEM CELLS · doi:10.1002/stem.160413 · Cited by 985
Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)
Lu, Y., Zi, X., Zhao, Y., Mascarenhas, D., & Pollak, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1852 · Cited by 882
Yakes, F. M., Chinratanalab, W., Ritter, C. A., King, W., SEELIG, S. A., & Arteaga, C. L. (2002) · PubMed · Cited by 705
Cohort Studies of Fat Intake and the Risk of Breast Cancer — A Pooled Analysis
Hunter, D. J., Spiegelman, D., Adami, H.-O., Beeson, L., van den Brandt, P. A., Folsom, A. R., Fraser, G. E., Goldbohm, R. A., Graham, S., Howe, G. R., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340603 · Cited by 657
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski, M. X., Ja, L., Gd, L., Te, H., FENDLY, B. M., & Fox, J. A. (1999) · PubMed · Cited by 653
Hudziak, R. M., Schlessinger, J., & Ullrich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7159 · Cited by 625
Bartsch, H., Nair, J., & Owen, R. W. (1999) · Carcinogenesis · doi:10.1093/carcin/20.12.2209 · Cited by 480
Biologic and therapeutic role of HER2 in cancer
Ménard, S., Pupa, S. M., Campiglio, M., & Tagliabue, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206779 · Cited by 432
Association of Dietary Intake of Fat and Fatty Acids With Risk of Breast Cancer
Holmes, M. D., Hunter, D. J., Colditz, G. A., Stampfer, M. J., Hankinson, S. E., Speizer, F. E., Rosner, B., & Willett, W. C. (1999) · JAMA · doi:10.1001/jama.281.10.914 · Cited by 376
Klapper, L. N., Waterman, H., Sela, M., & Yarden, Y. (2000) · PubMed · Cited by 351
Dietary fat, olive oil intake and breast cancer risk
Martin‐Moreno, J. M., Willett, W. C., Gorgojo, L., Banegas, J. R., Rodriguez‐Artalejo, F., Fernandez‐Rodriguez, J. C., Maisonneuve, P., & Boyle, P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580604 · Cited by 300
P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells
Nahta, R., Takahashi, T., Ueno, N. T., Hung, M.-C., & Esteva, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3900 · Cited by 298 · cited 5×
“The sensitizing effects of OA on trastuzumab efficacy were also accompanied by the upregulation and nuclear accumulation of p27, a CDKi playing a key role in the onset and progression of Her2/neu-induced breast tumorigenesis that has recently been implicated in the development of trastuzumab resistance in breast cance…”
BackgroundResultInfluentialTan, M., Yao, J., & Yu, D. (1997) · PubMed · Cited by 261
Rose, D. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.6.1513s · Cited by 210
Lu, Y., Zi, X., & Pollak, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.11445 · Cited by 208
Ip, C. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.6.1523s · Cited by 197
Breast Cancer: Weighing the Evidence for a Promoting Role of Dietary Fat
Wynder, E. L., Cohen, L. A., Muscat, J. E., Winters, B., Dwyer, J. T., & Blackburn, G. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.766 · Cited by 177
Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer.
Dowsett, M. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080191 · Cited by 171
The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
Xing, X., Wang, S.-C., Xia, W., Zou, Y., Shao, R., Kwong, K. Y., Yu, Z., Zhang, S., Miller, S., Huang, L., et al. (2000) · Nature Medicine · doi:10.1038/72294 · Cited by 164
Olive Oil and Human Cancer: An Assessment of the Evidence
Lipworth, L., Martínez, M. E., Angell, J. E., Hsieh, C., & Trichopoulos, D. (1997) · Preventive Medicine · doi:10.1006/pmed.1996.9977 · Cited by 156
Development of Herceptin resistance in breast cancer cells
Kute, T. E., Läck, C. M., Willingham, M. C., Bishwokama, B., Williams, H. C., Barrett, K., Mitchell, T., & Vaughn, J. P. (2003) · Cytometry Part A · doi:10.1002/cyto.a.10095 · Cited by 136
Muraoka, R. S., Lenferink, A. E. G., Law, B. K., Hamilton, E., Brantley, D. M., Roebuck, L. R., & Arteaga, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2204-2219.2002 · Cited by 134
Role of erbB2 in breast cancer chemosensitivity
Yu, D., & Hung, M. (2000) · BioEssays · doi:10.1002/1521-1878(200007)22:7<673::aid-bies10>3.0.co;2-a · Cited by 130
Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study
Simonsen, N., Navajas, J. F.-C., Martin-Moreno, J. M., Strain, J., Huttunen, J. K., Martin, B. C., Thamm, M., Kardinaal, A. F. M., Veer, P. V., Kok, F. J., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.1.134 · Cited by 95
Lee, M. M., & Gomez, S. L. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.221 · Cited by 87
Solanas, M., Hurtado, A., Costa, I., Moral, R., Menéndez, J. A., Colomer, R., & Escrich, E. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.4.745 · Cited by 77
Self-citationHER2 overexpression and cancer targeting
Wang, S., & Hung, M.-C. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90289-1 · Cited by 76
A rationale for dietary intervention in postmenopausal breast cancer patients: An update
Cohen, L. A., Rose, D. P., & Wynder, E. L. (1993) · Nutrition and Cancer · doi:10.1080/01635589309514231 · Cited by 63
Hudelist, G., Köstler, W. J., Attems, J., Czerwenka, K. F., Müller, R., Manavi, M., Steger, G. G., Kubista, E., Zielinski, C. C., & Singer, C. F. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601160 · Cited by 62
Dietary Fat, Calorie Restriction, Ad Libitum Feeding, and Cancer Risk
Pariza, M. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1987.tb06064.x · Cited by 61
Take Your Partners, Please — Signal Diversification by the erbB Family of Receptor Tyrosine Kinases
Daly, R. J. (1999) · Growth Factors · doi:10.3109/08977199909069144 · Cited by 61
Willett, W. C. (1999) · Toxicological Sciences · doi:10.1093/toxsci/52.suppl_1.127 · Cited by 40
ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1
Hulit, J., Lee, R. J., Russell, R. G., & Pestell, R. G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01145-0 · Cited by 38
Fatty Acids and Breast Cancer Cell Proliferation
Hardy, R. W., Wickramasinghe, N. S. M. D., Ke, S. C., & Wells, A. H. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-2670-1_5 · Cited by 17
Cited by
The role of lipids in cancer progression and metastasis
Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C., & Benitah, S. A. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.023 · Cited by 563
An Overview of the Modulatory Effects of Oleic Acid in Health and Disease
Sales-Campos, H., Reis de Souza, P., Crema Peghini, B., Santana da Silva, J., & Ribeiro Cardoso, C. (2013) · Mini Reviews in Medicinal Chemistry · doi:10.2174/138955713804805193 · Cited by 543
Glycerolipid Metabolism and Signaling in Health and Disease
Prentki, M., & Madiraju, S. R. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0007 · Cited by 326
Physiological, biochemical and molecular changes occurring during olive development and ripening
Conde, C., Delrot, S., & Gerós, H. (2008) · Journal of Plant Physiology · doi:10.1016/j.jplph.2008.04.018 · Cited by 265
Buckland, G., Travier, N., Cottet, V., González, C. A., Luján‐Barroso, L., Agudo, A., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27958 · Cited by 238
Metadata
- Authors
- Menendez, J. A., Vellon, L., Colomer, R., & Lupu, R.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 16
- Issue
- 3
- Pages
- 359-371
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2120487427
- Cited by
- 263
- References
- 46
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.